What is coronary artery computed tomography angiography (CTA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Coronary Artery CTA?

Coronary computed tomography angiography (CTA) is a noninvasive imaging technique that uses multidetector CT scanning with intravenous iodinated contrast to directly visualize the coronary arteries, assess for atherosclerotic plaque (both calcified and noncalcified), and detect coronary stenosis. 1

Technical Overview

Coronary CTA employs multidetector computed tomography (MDCT) technology to acquire high-resolution images of the coronary arteries. The procedure involves:

  • Intravenous injection of iodinated contrast media to opacify the coronary vessels 1
  • Image acquisition synchronized with the cardiac cycle to minimize motion artifact
  • Spatial resolution capable of visualizing vessels as small as 1.5 to 2 mm in diameter 1
  • Post-processing on specialized workstations using multiplanar reformations, curved multiplanar reformations, and thin maximum-intensity projections 1

The technique has evolved to achieve high sensitivity and specificity for detecting coronary artery disease, with excellent negative predictive value for ruling out significant stenosis 2, 3

What Coronary CTA Can Assess

The examination provides comprehensive evaluation of:

  • Coronary anatomy: Origin, course, and dominance (right vs. left) of coronary vessels 1
  • Atherosclerotic plaque: Both calcified and noncalcified plaque, unlike MRA which cannot easily differentiate between the two 1
  • Stenosis severity: Detection of hemodynamically significant narrowing in vessels ≥1.5-2 mm diameter 1
  • Coronary anomalies: Anomalous coronary artery origin and course 1
  • Coronary aneurysms: Location and size of aneurysmal or pseudoaneurysmal dilatations 1
  • Bypass graft patency: Assessment of coronary artery bypass grafts 1
  • Incidental findings: Valves, great arteries, myocardium, pericardium, and adjacent lung tissue are also visualized 1

Clinical Applications

The primary clinical role is exclusion of significant CAD in symptomatic patients at intermediate risk after initial risk stratification, including those with equivocal stress test results 1. The American Heart Association guidelines specifically state that coronary CTA is reasonable for this population (Class IIa, Level of Evidence B) 1.

Appropriate Use:

  • Symptomatic patients with intermediate pretest probability of CAD 1, 3
  • Evaluation of chest pain with nondiagnostic stress tests 4
  • Assessment of suspected coronary anomalies 1
  • Emergency department triage of acute chest pain patients 3
  • Evaluation of unexplained left ventricular dysfunction 4

Inappropriate Use:

  • Screening asymptomatic patients is contraindicated (Class III, Level of Evidence C) 1, 3
  • High pretest probability patients who will likely require invasive angiography anyway 1
  • Very low pretest probability patients (radiation exposure not justified) 1

Important Limitations and Risks

Radiation Exposure

The predominant risk is radiation exposure, particularly concerning in children where projected lifetime cancer mortality from CT radiation is significantly higher than in adults 1. Modern techniques have reduced doses substantially, often to less than half that of myocardial perfusion imaging 5.

Technical Limitations:

  • Heavy coronary calcification causes false-positive findings and may render segments non-evaluable 1, 3
  • Coronary stents (especially <3.0 mm diameter): Lumen not well visualized within stents 1, 4
  • High or irregular heart rates: Degrade image quality 1
  • Renal dysfunction: Contraindication due to iodinated contrast nephrotoxicity 1
  • Contrast allergy: Risk of anaphylactoid reaction 1

Common Pitfalls:

  • Lower spatial resolution than invasive angiography 1
  • Metal artifacts from sternal wires or stents may obscure adjacent vessels 1
  • Respiratory or cardiac motion can compromise image quality 1

Diagnostic Performance

Studies demonstrate sensitivity of 85-100% and specificity of 88-100% for detecting significant coronary stenosis (≥50% luminal narrowing) 1. The excellent negative predictive value makes CTA particularly valuable for ruling out disease rather than confirming it 2, 3.

Emerging Technologies

Advanced applications now include:

  • CT-derived fractional flow reserve (FFR-CT): Noninvasive hemodynamic assessment of stenosis significance 5, 6
  • Quantitative plaque analysis: Assessment of plaque burden and high-risk features 7, 8
  • CT perfusion: Functional assessment combined with anatomy 5
  • Artificial intelligence: Enhanced image interpretation and plaque characterization 7, 8

References

Related Questions

What test can detect coronary artery narrowing?
Does a patient need a driver after a coronary computed tomography angiography (CTA) with contrast?
Can a coronary computed tomography angiography (CCTA) with calcium score be ordered for a patient with coronary artery disease (CAD) and a stent placement, given a family history of myocardial infarction (MI)?
Is coronary computed tomography angiography (CTA) indicated before a Hyrox race for a 34-year-old woman with no medical history and no family history of premature cardiovascular disease?
Can a coronary computed tomography angiography (CTA) be performed in a patient who has a coronary stent?
Which statement best reflects the findings of both the OASIS‑4 elizanetant study and the URCC 19075 exercise trial?
What is the correct dose of Mucinex Fast‑Acting DM (guaifenesin + dextromethorphan) for an 8‑year‑old child weighing 90 lb (≈41 kg)?
What is Lybalvi (olanzapine/samidorphan), its indications, recommended dosing, contraindications, and required monitoring?
What could cause tachycardia of 112 bpm with oxygen saturation of 97% in an elderly patient after recent hospital discharge?
How should symptomatic adenomyosis be managed in a reproductive‑age woman?
In a 64-year-old man with de novo low-volume metastatic hormone-sensitive prostate cancer receiving continuous androgen deprivation therapy (ADT) plus enzalutamide, who has undetectable PSA after 20 months but significant fatigue, hot flashes, decreased libido, and cognitive slowing, what does the current evidence indicate regarding intermittent versus continuous therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.